Cost Analysis of DPP4 and SGLT2 Inhibitors - "Dilemma of the Prescribing Physician - Which Brand to Choose?"

• Asıl Yazarlar: Hiteswar Saikia (Yazar), Prabhat Ranjan Baruah (Yazar), Anju L Saikia (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Krupanidhi College of Pharmacy, 2024-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Diabetes mellitus (DM) is a complex and heterogeneous group of chronic metabolic diseases causing dreaded complications increasing human sufferings, and a costly disease to manage in low/middle-income countries, which is burdensome for the most vulnerable populations, cause financial strain on indiv...